Westlake Chemical Partners LP Files 8-K on Operations and Disclosure

TL;DR

**Westlake Chemical Partners LP just dropped an 8-K on Feb 20, covering their latest financial results and disclosures.**

AI Summary

Westlake Chemical Partners LP filed an 8-K on February 20, 2024, reporting on 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure'. The filing indicates that the earliest event reported also occurred on February 20, 2024. This report was filed from their principal executive offices at 2801 Post Oak Boulevard, Suite 600, Houston, Texas 77056.

Why It Matters

This filing provides an update on Westlake Chemical Partners LP's financial condition and operations, offering transparency to investors and the market.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial condition and operations, not indicating any immediate new risks.

Key Players & Entities

• Westlake Chemical Partners LP (company) — Registrant
• February 20, 2024 (date) — Date of earliest event reported and filing date
• Houston, Texas (location) — Principal executive offices
• 77056 (location) — Zip Code of principal executive offices
• 001-36567 (other) — Commission File Number

FAQ

Filing Documents

• wlkp-20240220.htm (8-K) — 26KB
• ex991_231231earningsrelease.htm (EX-99.1) — 203KB
• 0001604665-24-000003.txt ( ) — 370KB
• wlkp-20240220.xsd (EX-101.SCH) — 2KB
• wlkp-20240220_lab.xml (EX-101.LAB) — 25KB
• wlkp-20240220_pre.xml (EX-101.PRE) — 13KB
• wlkp-20240220_htm.xml (XML) — 3KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On February 20, 2024 , Westlake Chemical Partners LP (the "Partnership") issued a press release announcing its 2023 fourth quarter and full year results. A copy of the press release is furnished with this Current Report as Exhibit 99.1. The information furnished pursuant to this Current Report, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing by Westlake Chemical Partners LP under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, unless specifically identified as being incorporated therein.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. The Partnership is holding a conference call on February 20, 2024 to discuss its 2023 fourth quarter and full year results. Information about the call can be found in the press release furnished with this Current Report as Exhibit 99.1.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit is furnished herewith: 99.1 Press release issued on February 20, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WESTLAKE CHEMICAL PARTNERS LP By: Westlake Chemical Partners GP LLC Date: February 20, 2024 By: /S/ ALBERT CHAO Albert Chao President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR